ACOG Alpha Cognition Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ACOG

Price (delayed)

$9.22

Market cap

$200.79M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.09

Enterprise value

$159.35M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 90
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 27

Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and cognitive Impairment with mild Traumatic Brain ...

Highlights
ACOG's gross profit is up by 45% QoQ
ACOG's revenue is up by 41% since the previous quarter
Alpha Cognition's equity has soared by 66% YoY but it has decreased by 8% from the previous quarter
The net income is up by 16% since the previous quarter but it has declined by 3.8% year-on-year
The quick ratio has contracted by 46% YoY and by 31% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.alphacognition.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of ACOG

ACOG stock price

How has the Alpha Cognition stock price performed over time
Intraday
-1.02%
1 week
-5.29%
1 month
9.37%
1 year
12.99%
YTD
41.85%
QTD
27.7%

Financial performance

How have Alpha Cognition's revenue and profit performed over time
Revenue
$15.26M
Gross profit
$13.72M
Operating income
-$29.09M
Net income
-$23.44M
Gross margin
89.9%
Net margin
-153.6%
The operating income has plunged by 71% YoY but it has grown by 2.3% from the previous quarter
ACOG's net margin has soared by 69% year-on-year and by 40% since the previous quarter
Alpha Cognition's operating margin has increased by 49% YoY and by 31% from the previous quarter
ACOG's gross profit is up by 45% QoQ

Price vs fundamentals

How does ACOG's price correlate with its fundamentals

Growth

What is Alpha Cognition's growth rate over time

Valuation

What is Alpha Cognition stock price valuation
P/E
N/A
P/B
3.79
P/S
13.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.44
ACOG's EPS is up by 38% year-on-year and by 28% since the previous quarter
Alpha Cognition's equity has soared by 66% YoY but it has decreased by 8% from the previous quarter
The P/B is 47% more than the last 4 quarters average of 2.6
ACOG's revenue is up by 41% since the previous quarter
The P/S is 14% above the last 4 quarters average of 11.7

Efficiency

How efficient is Alpha Cognition business performance
Alpha Cognition's ROIC has soared by 95% YoY and by 42% from the previous quarter
ACOG's return on sales has surged by 70% year-on-year and by 41% since the previous quarter
The return on equity has increased by 45% year-on-year and by 25% since the previous quarter
ACOG's ROA is up by 40% year-on-year and by 22% since the previous quarter

Dividends

What is ACOG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACOG.

Financial health

How did Alpha Cognition financials performed over time
The quick ratio has contracted by 46% YoY and by 31% from the previous quarter
The total assets has grown by 43% YoY but it has contracted by 7% from the previous quarter
ACOG's debt is 100% smaller than its equity
Alpha Cognition's equity has soared by 66% YoY but it has decreased by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.